Webinar | Insights from 10,000 GLP-1 users

GLP-1s: Real-world insights from 10,000 users

The obesity treatment landscape is evolving rapidly with the proliferation of GLP-1s, but traditional real-world data (RWD) sources lack context, completeness, and the ability to track patient experiences over time. This webinar explores how Evidation’s direct-to-individual approach to collecting RWD—engaging people before they become patients—is unlocking new insights that can transform patient understanding.

Learn how Evidation is using an established, direct connection to 5 million people to:

Download a copy of the presentation slides here .

Watch the webinar here.

Related Therapeutic Areas: